<DOC>
	<DOC>NCT01191177</DOC>
	<brief_summary>The purpose of this study is to investigate the usefulness of oral fish oil(Lovaza)in normalizing liver function in patients who have parenteral nutrition associated liver disease. The investigators believe that patients who take oral fish oil will normalize liver function faster than those who do not</brief_summary>
	<brief_title>Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<criteria>History of parenteral nutrition(PN)administration &gt;4weeks PN associated liver disease from intestinal failure ability to take full enteral feed body weight equal or greater than 3kg elevated ALT level twice of that normal(ALT&gt;84)at the time PN is weaned off Hemodynamic instability renal failure suspected congenital obstruction of the hepatobiliary system diagnosis hepatitis A, B, or C diagnosis of alpha 1antitrypsin deficiency diagnosis of cytomegalovirus infection diagnosis of HIV children in care</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>oral fish oil</keyword>
	<keyword>Lovaza</keyword>
	<keyword>Omega-3-acid supplementation</keyword>
	<keyword>Faster normalization of ALT with oral fish oil</keyword>
	<keyword>Faster normalization of liver function test with oral fish oil</keyword>
	<keyword>Increased growth with oral fish oil</keyword>
</DOC>